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doi:10.1016/j.joca.2012.02.008Mankin and colleagues have written one of the most extraordi-
nary papers ever published1 more than 20000 times cited since its
publication in 1971. This not because of the doubtless scientiﬁc
merits of this paper or its main author, but because this paper pre-
sented a simple, to some extent biologically intuitive grading
system of osteoarthritic cartilage changes, which has not had any
competitive alternative since 40 years. However, this grading
system never received textbook status: thus, everybody felt it
necessary to keep citing it because people kept modifying and crit-
icizing it. The new paper by Pauli and colleagues published in this
volume of Osteoarthritis and Cartilage continues in this tradition,
so Mankin et al.1971will presumably remain the evergreen of oste-
oarthritis research in at least the near future. In this new paper, the
Mankin score is compared to a scoring system recently proposed by
Pritzker and colleagues2, which was suggested to be more reliable
and appropriate than Mankin’s system.
What is the issue about?
No doubt, histopathological grading of osteoarthritic (OA) carti-
lage lesions is important. Grading and staging in a standardized
manner is even more important for the international science
community in order to know what is investigated in the studies
and to be able to compare different studies. However, the Mankin
system has never been validated regarding the relevance of the
parameters used (structural matrix changes, cellular changes,
proteoglycan loss, tidemark alterations) or the metric properties
of the score for the development and progression of OA, and the
same applies for the grading system proposed by Pritzker and
colleagues. Such a validation is nearly unfeasable in the human as
longitudinal studies in patients are at least for the moment impos-
sible and the correlation of histopathological changes with the clin-
ical picture is weak. Moreover, studies in animal models are of
limited value as we cannot be sure that an animal model system
really reﬂects the human situation at the histomorphological levelResearch Society International. Pu(in fact, many relevant differences are obvious in various animal
model systems).
No doubt, theMankin systemhas quite a few sincere limitations:
one draw-back is the use of qualitative/semi-quantitative scoring
units (e.g. slight, moderate, strong) which can cause scoring vari-
ability in borderline cases. Second, some scorings do not describe
primary OA cartilage, but are more appropriate for secondary carti-
lage formation (osteophytic cartilage) or overgrowing synovial
tissue, namely total disorganization of PG-staining, pannus-like
tissue at the surface and the penetration of the tidemark bymultiple
vessels.
One other important limitation is that Mankin’s system (as most
other scoring systems) does not take the relative importance of the
different cartilage pathology parameters scored into account, i.e.
there is no apparent rationale or evidence for how many points
are given to what feature. This again reﬂects our failure of knowl-
edge on which structural changes are the most important in the
pathophysiology, progression or treatment of OA.
The clear advantage of the Mankin system is that it lists several
"at ﬁrst sight reasonable" pathology-associated parameters (struc-
tural disintegration, matrix/proteoglycan loss, cellular alterations,
and alterations of the tidemark), parameters intuitive for every
OA histopathologist in routine work. These features have face
validity.
The Pritzker score ﬁnally comes back to the main criterion,
“structural matrix integrity”, which somehow translates macro-
scopic alterations to the histological level (normal – some sort of
alteration without surface disruption – discontinuity – (vertical)
ﬁssuring – (partial) erosion – complete erosion (¼denudation) –
(bone) deformation). In this respect, it clearly weights changes by
taking only one as primary criterion. In addition to the articular
cartilage, the Pritzker score extends the proposed grades by
including the subarticular bone (grade 6). Bone is, however, for
various reasons often not available, neither in routine pathology
nor in the experimental set-up. In practice, bone changes are rather
a disease staging parameter than a grading tool (for the deﬁnition
of the various scoring activities see Table I).blished by Elsevier Ltd. All rights reserved.
Table I
Deﬁnitions of important terms related to the evaluation of joint pathology6
Term Explanation
Assessing/evaluating General activity of analyzing something
Scoring A general term denoting an evaluation or
assessment performed in a (semi) quantitative
or qualitative manner
Measuring Assessing/evaluating something in
a quantitative manner
Grading Scoring microscopically or macroscopically at
a speciﬁc site or region
Staging Scoring the overall disease status (mostly done
macroscopically, but can also be done
microscopically, e.g. histologically whereby
grades are multiplied by extent of lesions; could
also be performed radiographically or clinically)
Extent/extension Geographic area or scope of tissue involvement
(i.e. cartilage, bone, joint capsule etc.)
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parameters and might thus be of little help in many instances for
characterising OA cartilage samples. This was presumably a core
reason for Pritzker and colleagues to add supplementary criteria
and subgrades. However, these supplementary criteria may add
more confusion than help as they are not speciﬁc for one grade.
As nicely pointed out by Kenneth Pritzker2, an appropriate
scoring system should fulﬁll several basic criteria: simplicity, utility,
scalability, extendibility and comparability. Nothing needs to be
added per se to this list of primary goals except one of the most
basic theorems of modern epistemology: one should not add theo-
rems without any proven utility and need because this increases
conceptual disarrangement rather than scientiﬁc knowledge. This
does not mean that one should not propose new hypotheses for
scientiﬁc evaluation, but for suggesting a proposal as a new para-
digm it needs to follow this rule. Exactly this appears to be an issue
with the new histopathology grading system suggested by Pritzker
and colleagues in 20062: it introduced a new system on a rather
authoritative basis (“OARSI” grading system) with no real evidence
that the older one (i.e. the Mankin system) is inferior. In this
respect, modern science is rather conservative and restrictive.
The paper by Pauli and colleagues on “Comparison of cartilage
histopathology assessment systems on human knee joints at all
stages of osteoarthritis development” in this volume of Osteoar-
thritis and Cartilage shows that both grading systems are reliable
and correlate to each other. This is not surprising. The major
message appears to be that all the doubts about the reproducibility
of the Mankin grade are not really valid. In fact, a more simple
scoring system is difﬁcult to imagine as long as one is professionally
trained to evaluate histological sections. If we recall that doubts on
the reliability3,4 were themajor reason to develop a new “more reli-
able” system we might question the need for or utility of a new
system. In fact, as long as we do not knowmore about the biological
relevance of observed changes in OA tissues, changing grading
system may be of little help.What might to be the way to go?
First, we need to clarify the language used: this includes a basic
understanding of descriptors. A consensus proposal was recently
published in Osteoarthritis and Cartilage5 and is recommended
until a new consensus proposal (if needed) is agreed upon by the
expert community. This should include a basic agreement on the
terminology of the evaluation activity6 (Table I).
Second, the comparability of different studies is so important
that for the sake of scientiﬁc progress we are often better off
sticking to one potentially sub-optimal system than to use manydifferent systems. This lesson has been learned from other ﬁelds
such as lymphoma classiﬁcation. An option is to use a second
scoring system in parallel, which might be more optimized for
the actual study purposes.
Sowhich scoring system to use? It is the feeling of this author that
for grading cartilage samples from experimental studies theMankin
system remains superior as it offers a wider range of classiﬁcation
criteria without inconsistencies in between grades: the Mankin
system offers a range of 14 points compared to 3 (to 4) applicable
grades: grades 0 and 1 within the Pritzker system are basically
normal or minor changes (potentially age-related), and grades 5
and 6 are not applicable for cartilage samples. Clinical/pathological
full thickness biopsies for diagnosis and staging of the disease
provide a different challenge: for these, the proposal by Pritzker
and colleagues is superior. However, clinical staging/diagnostic spec-
imens are rather the exception and not the focus of this editorial.
We need to validate any proposed new criteria intended to
deﬁne an improved scoring system, but this requires a better
understanding of the natural course of OA cartilage degeneration.
It is possible that no single grading system can cover all needed
uses, but that we may need different scoring systems for different
aspects and interests. Different scoring systems can be appropriate
if one is interested in staging the disease (e.g. studying the diag-
nosis and prognosis of the individual patient condition) or if one
is interested in selecting patients for certain therapeutic
approaches such as anti-catabolic, anti-proliferative or anti-
apoptotic regimens. The latter may require scoring categories
related to the effects of interest, i.e. proteoglycan distribution/
loss, chondrocyte proliferation/clustering and cell loss/apoptosis.
Last not least, any evaluation system is only as good as the eval-
uators, i.e. as good as the evaluators trained in the skills needed.
Optimally, histopathological evaluation in OA research and diag-
nostic practice should be done by trained histo(patho)logists.References
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